An observational study in Chronic Pain, sponsored by University Hospital, Brest. Recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-16.
Sponsored by University Hospital, Brest · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 135 studies in Chronic Pain with a site in France — 35 open to participants now, 39 under way, 2 of them phase 3. Chronic Pain · France.
Among the 135 studies in Chronic Pain with a site in France, this one is the 48th largest by planned enrollment of the 68 observational ones that give a count, is one of 11 that started in 2026, is one of 68 observational ones, reaches primary completion later than 12 of the 38 other live ones, and was the 120th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →35 of the 135 studies in Chronic Pain with a site in France are open now. Recruiting first, the newest first:
Nantes University Hospital · Sites in France
Ages 18+
Institut Rafael · Sites in France
Ages 18+
Hospital Ambroise Paré Paris · Sites in France
Ages 18–80
Centre Medical ISM (Integrative Systemic Medicine) · Sites in France
Ages 18+
Medtronic · Sites in France, United States, Belgium and 1 more country
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
135 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 7 · Phase 3 13 · Phase 4 3
First in 2003; this study’s year is marked. 11 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 88 is below the median of 120 across 755 observational studies indexed under Chronic Pain.
Median enrollment 78 across the 67 interventional studies, 160 across the 68 observational. Of the 84 that completed or were terminated, 11 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
21 of 135 have an industry lead sponsor. The 10 most frequent:
University Hospital, Brest is the lead sponsor of 602 studies on the registry; 137 are open to participants now.
University Hospital, Brest has 4 studies filed under Chronic Pain — fewer than ten, so there is no comparison to draw.
14 of the studies in Chronic Pain with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06964243Institut pour la Pratique et l'Innovation en PSYchologie appliquée (Institut Pi-Psy)Protocol Assessment of Motor Cortex rTMS for Treating Neuropathic Pain | 2026-12-19 |
| NCT07877376Nadine ATTALImpact of Cognitive Impairment on Chronic Pain in Breast Cancer | 2027-01 |
| NCT06811077Fondation Hôpital Saint-JosephEvaluation of Individual Health Coaching Sessions Provided by a Patient Expert As Part of Therapeutic Education for Patients Registered At the Chronic Pain Consultation | 2027-01-15 |
| NCT07280338University Hospital, BrestEmotional Intelligence and Chronic Orofacial Pain | 2027-02-09 |
| NCT06841276NovesiaImpact of QoLibri Medical Device on the Consequences of Chronic Pain: a Randomized Controlled Trial | 2027-03 |
Add all 14 to your calendar (.ics) → With an account.
Among the 135 studies in Chronic Pain with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Chronic pain, lasting more than three months, is a widespread health issue that negatively impacts daily life, leading to significant emotional distress and functional impairment. Emotional intelligence, defined as the ability to recognize and manage one's own emotions as well as those of others, has been linked to better communication skills and reduced stress, which is a well-known risk factor for chronic pain. Studies have highlighted a correlation between emotional intelligence and certain chronic pain conditions, such as fibromyalgia and migraines. However, no research has yet explored its role in painful temporomandibular disorders (TMD). Given the strong involvement of psychosocial factors in TMD etiology, a better understanding of these elements could improve pain management and pave the way for preventive interventions.
This project aims to compare emotional intelligence and various psychosocial factors (anxiety, depression, coping, emotional regulation) between patients with painful temporomandibular disorder (TMD) and a control group without TMD or chronic pain. The study is based on the administration of validated French-language questionnaires during routine dental medicine consultations. Each participant completes these questionnaires in approximately 15 minutes, without any modification to their care. The data collected will help assess the relationships between orofacial pain and emotional factors to improve the understanding and management of affected patients.
Regarding the evaluated population (cases), approximately 30 patients are seen each week in the oral health service for chronic orofacial pain consultations. About 60% of these patients have a diagnosis of painful TMD, which is around 18 patients per week. Including 44 patients in this study over a 6-month period thus seems feasible.
Regarding the control population, more than 50 patients are seen daily in oral rehabilitation consultations at the oral health service of the CHU de Brest. These controls will be matched in gender and age (+/- 5 years) with the studied population (cases). The significant proportion of these patients should allow for the feasibility of this matching.
Inclusion Criteria:
For all subjects:
Major subject
Diagnosis of temporomandibular dysfunction -No other diagnosis of chronic pain
For subjects in the control group:
-No diagnosis of chronic pain
Non inclusion Criteria:
All included subjects will have the same participation, which consists of completing several standardized questionnaires. These questionnaires assess various psychological and emotional aspects, including anxiety and depressive disorders (HADS questionnaire), coping strategies (Brief-COPE score), emotional regulation (ERS score), fatigue level (EVA scale), and emotional intelligence (TEIQue-SF questionnaire) to compare scores between the DTM group and the control group. Additionally, sociodemographic and psychosocial criteria will be collected to refine the analysis of the results. The completion of these questionnaires is part of routine consultations and does not alter the patients' standard care.
Other: Questionnaire and Physical Exam
All included subjects will be required to complete the following questionnaires: Hospital Anxiety and Depression Scale (HADS) Brief-COPE for coping assessment Emotion Reactivity Scale (ERS) for emotional regulation Visual Analog Scale (VAS) for fatigue assessment Sociodemographic and psychosocial evaluation Trait Emotional Intelligence Questionnaire - Short Form (TEIQue-SF) for emotional intelligence assessment
Measurement of emotional intelligence score between both groups
Measurement of emotional intelligence score assessed by the TEIQue-SF questionnaire : The short version consists of 33 items assessing four factors: well-being, self-control, emotionality, and sociability. Each item is rated on a Likert scale ranging from 1 ("strongly disagree") to 7 ("strongly agree").
Time frame: Day 0
Measurement of anxiety disorders between both groups
Measurement of anxiety disorders between the two groups via the HAD-S questionnaire The HAD scale is a validated instrument in French, used to screen for anxiety and depressive disorders. It consists of 14 items scored from 0 to 3. Seven questions relate to anxiety (total A) and the other seven to the depressive dimension (total D), thus providing two scores (maximum score for each = 21). This questionnaire is routinely used during consultations in the oral health service and systematically used during specialized consultations for orofacial pain.
Time frame: Day 0
Measurement of the coping score between both groups
Measurement of the coping score assessed by the Brief-COPE questionnaire This instrument is an abbreviated version of the COPE inventory with 28 items. It includes 14 scales that assess distinct dimensions of coping: active coping, planning, instrumental social support seeking, emotional social support seeking, emotional expression, behavioral disengagement, distraction, blaming, positive reinterpretation, humor, denial, acceptance, religion, and substance use.
Time frame: Day 0
Measurement of emotional regulation score between both groups
Measurement of emotional regulation score assessed by the ERS questionnaire The ERS is a self-report questionnaire with 21 items designed to measure, using a single tool, three dimensions of emotional reactivity: emotional sensitivity, intensity, and persistence of emotions. Each item is rated on a Likert scale ranging from 0 ("does not apply to me at all") to 4 ("applies to me perfectly").
Time frame: Day 0
Measurement of fatigue score between both groups
Measurement of fatigue score assessed by an EVA scale (From 0 to 10)
Time frame: Day 0
Measurement of Depression disorders between both groups
Measurement of depression disorders between both groups via the HAD-S questionnaire The HAD scale is a validated instrument in French, used to screen for anxiety and depressive disorders. It consists of 14 items scored from 0 to 3. Seven questions relate to anxiety (total A) and the other seven to the depressive dimension (total D), thus providing two scores (maximum score for each = 21). This questionnaire is routinely used during consultations in the oral health service and systematically used during specialized consultations for orofacial pain.
Time frame: Day 0
Plan to share: Undecided
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Feb 2027, 12 months after the start.
Of 337 non-industry observational studies under Chronic Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 56. This study's planned 12 months is below that.
Counting every sponsor, half of 363 studies reached it within 24 months; a quarter within 12 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.